Hosted on MSN7m
We Asked Retail Traders About Eli Lilly’s Biggest Post-Q4 Risk — Most Say It’s The Weight-Loss Drug Wars
Shares of Eli Lilly finished Thursday 3% higher despite an earnings report that showed sales of its blockbuster GLP-1 ...
healthday50m
'Ozempic Face' and Other Top Trends in Plastic Surgery
Surgical tweaks for “Ozempic face” are on the rise. The latest report from AAFPRS reveals a 50% increase in facial fat ...
The wealthy 1% are turning to new status symbols that can’t be bought—and it’s hurting Dior, Versace, and Burberry
The ultra-rich are turning to new ways to signal wealth as luxury dupes, weight-loss drugs, and cosmetic procedures become ...